Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Cordis reports positive trial results for its SELUTION SLR balloon, showing reduced reblockage in peripheral artery disease patients.

flag Cordis reported positive results from two clinical trials of its SELUTION SLR drug-eluting balloon, showing improved outcomes in patients with peripheral artery disease, including reduced rates of target lesion revascularization and restenosis. flag The findings were presented at a medical conference and support the device’s potential to enhance long-term vascular patency.

5 Articles